TransMed7, LLC

16 articles about TransMed7, LLC

• TransMed7, LLC Announces First Revenue from Concorde Family of Devices

  9/6/2023

  TransMed7, LLC announced the first sales of Concorde ) Soft Tissue Biopsy devices, to the Margaret West Comprehensive Breast Center in Germantown, TN.

• TransMed7, LLC Announces First Clinical Use of VacuPac®, a New Self-Contained, Vacuum-Assist Attachment for all of its Vacuum-Assisted, Single Insertion - Multiple Collection (SIMC®) Platforms of Biopsy Devices

  3/21/2023

  TransMed7, LLC announced the first clinical use of VacuPac®, a new self-contained external vacuum-assist attachment with a SpeedBird Universal and a Concorde US from the SpeedBird and Concorde families of vacuum-assisted, Single Insertion – Multiple Collection breast biopsy devices.

• TransMed7, LLC Announces First Clinical Cases of Concorde Soft Tissue Biopsy Devices for Commercial Launch

  2/6/2023

  TransMed7, LLC announced today that the “First in Human” series of clinical cases using commercial production Concorde US devices.

• TransMed7, LLC Announces First Clinical Use of Heron Soft Tissue Biopsy Devices for Commercial Launch

  8/16/2022

  TransMed7, LLC announced today that the “First in Human” clinical case of the commercial production version of a Heron™ XPS device (a member of the new Heron™ family of vacuum-assisted, Single Insertion / Multiple Collection (SIMC®) Soft Tissue Biopsy devices) was successfully performed by Dr. Edgar Staren.

• TransMed7, LLC Announces First Clinical Use of SpeedBird™ Breast Biopsy Devices for Commercial Launch

  8/9/2022

  TransMed7, LLC announced today that the first clinical cases of the final commercial production version of the Sparrow device (a member of the new SpeedBird™ family of vacuum-assisted, Single Insertion / Multiple Collection (SIMC®) Breast Biopsy devices) were successfully performed by Dr. Edgar Staren, a distinguished surgeon and former President of the American Society of Breast Surgeons (ASBrS).

• TransMed7, LLC Announces the Availability of Concorde, the Stereotactic Table Variant of its SpeedBird Biopsy Device Platform

  9/18/2018

  “We are delighted to announce a letter-to-file regarding ConcordeTM, the stereotactic table variant of our FDA-cleared SpeedBirdTM soft tissue biopsy device platform,” stated Dr. James W. Vetter, TransMed7 Co-Founder and Chairman.

• TransMed7, LLC Announces Appointment of Dr. John Simpson as Strategic Advisor to Its Board of Directors

  7/30/2018

  TransMed7, LLC is delighted to announce the appointment of John B. Simpson, Ph.D., M.D., as Strategic Advisor to the TransMed7 Board of Directors.

• TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its SpeedBird Soft Tissue Biopsy Device Platform

  6/20/2018

  The SpeedBird platform is based on TransMed7’s patented Zero5TM work element composed of a fused, single element constructed from 3 hypotubes and forming rotating twin cutter blades.

• David Harding to Join TransMed7, LLC Business Advisory Board

  1/22/2018

  Mr. David Harding is currently the Senior Vice-President (SVP) of Corporate Strategy and Business Development at Exact Sciences, a diagnostics company focused on colorectal cancer screening.

• TransMed7, LLC Announces Inaugural Members of Its Business Advisory Board

  12/11/2017

  The TransMed7 BAB is composed of accomplished business experts offering innovative advice and dynamic perspectives that will contribute to the accomplishment of TransMed7’s tactical goals and strategic objectives.

• Transmed7 Announces 510(K) Submission to the FDA for Its Speedbird Soft Tissue Biopsy Device Platform

  10/17/2017

  The company has submitted a premarket notification for its innovative SpeedBird soft tissue biopsy device platform with FDA.

• TransMed7 Announces Endocrine And GI Health Chair Appointment

  10/10/2017

• TransMed7 Announces Breast Health Chair Appointment

  9/25/2017

• TransMed7 Announces Strategic Partnership With Peridot Corporation

  9/11/2017

• TransMed7 Announces Jack Cumming As Director

  7/24/2017

• TransMed7 Announces President Appointment

  7/14/2017